219 related articles for article (PubMed ID: 25273520)
1. Enhanced green fluorescent protein-mediated synthesis of biocompatible graphene.
Gurunathan S; Woong Han J; Kim E; Kwon DN; Park JK; Kim JH
J Nanobiotechnology; 2014 Oct; 12():41. PubMed ID: 25273520
[TBL] [Abstract][Full Text] [Related]
2. Green chemistry approach for the synthesis of biocompatible graphene.
Gurunathan S; Han JW; Kim JH
Int J Nanomedicine; 2013; 8():2719-32. PubMed ID: 23940417
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene.
Gurunathan S; Han JW; Park JH; Eppakayala V; Kim JH
Int J Nanomedicine; 2014; 9():363-77. PubMed ID: 24453487
[TBL] [Abstract][Full Text] [Related]
4. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Int J Nanomedicine; 2013; 8():1015-27. PubMed ID: 23687445
[TBL] [Abstract][Full Text] [Related]
5. Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.
Gurunathan S; Han JW; Kim ES; Park JH; Kim JH
Int J Nanomedicine; 2015; 10():2951-69. PubMed ID: 25931821
[TBL] [Abstract][Full Text] [Related]
6. A Novel Biomolecule-Mediated Reduction of Graphene Oxide: A Multifunctional Anti-Cancer Agent.
Choi YJ; Kim E; Han J; Kim JH; Gurunathan S
Molecules; 2016 Mar; 21(3):375. PubMed ID: 26999102
[TBL] [Abstract][Full Text] [Related]
7. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231).
Gurunathan S; Han J; Park JH; Kim JH
Int J Nanomedicine; 2014; 9():1783-97. PubMed ID: 24741313
[TBL] [Abstract][Full Text] [Related]
8. Improving dispersive property, biocompatibility and targeting gene transfection of graphene oxide by covalent attachment of polyamidoamine dendrimer and glycyrrhetinic acid.
Liu F; Yang D; Liu Y; Cao Q; Sun Y; Wang Q; Tang H
Colloids Surf B Biointerfaces; 2018 Nov; 171():622-628. PubMed ID: 30103151
[TBL] [Abstract][Full Text] [Related]
9. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
Chatterjee N; Eom HJ; Choi J
Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
[TBL] [Abstract][Full Text] [Related]
10. Systematic Assessment of the Toxicity and Potential Mechanism of Graphene Derivatives In Vitro and In Vivo.
Li J; Zhang X; Jiang J; Wang Y; Jiang H; Zhang J; Nie X; Liu B
Toxicol Sci; 2019 Jan; 167(1):269-281. PubMed ID: 30239936
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa.
Gurunathan S; Han JW; Dayem AA; Eppakayala V; Kim JH
Int J Nanomedicine; 2012; 7():5901-14. PubMed ID: 23226696
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Colloids Surf B Biointerfaces; 2013 May; 105():58-66. PubMed ID: 23352948
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells.
Gurunathan S; Han JW; Eppakayala V; Dayem AA; Kwon DN; Kim JH
Nanoscale Res Lett; 2013 Sep; 8(1):393. PubMed ID: 24059222
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility and hemocompatibility of hydrothermally derived reduced graphene oxide using soluble starch as a reducing agent.
Narayanan KB; Kim HD; Han SS
Colloids Surf B Biointerfaces; 2020 Jan; 185():110579. PubMed ID: 31689675
[TBL] [Abstract][Full Text] [Related]
15. Impact of Graphene-Based Surfaces on the Basic Biological Properties of Human Umbilical Cord Mesenchymal Stem Cells: Implications for Ex Vivo Cell Expansion Aimed at Tissue Repair.
Jagiełło J; Sekuła-Stryjewska M; Noga S; Adamczyk E; Dźwigońska M; Kurcz M; Kurp K; Winkowska-Struzik M; Karnas E; Boruczkowski D; Madeja Z; Lipińska L; Zuba-Surma EK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540083
[TBL] [Abstract][Full Text] [Related]
16. Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial.
Zhang XF; Gurunathan S
Int J Nanomedicine; 2016; 11():6635-6649. PubMed ID: 27994461
[TBL] [Abstract][Full Text] [Related]
17. Biofabrication of Lysinibacillus sphaericus-reduced graphene oxide in three-dimensional polyacrylamide/carbon nanocomposite hydrogels for skin tissue engineering.
Narayanan KB; Choi SM; Han SS
Colloids Surf B Biointerfaces; 2019 Sep; 181():539-548. PubMed ID: 31185446
[TBL] [Abstract][Full Text] [Related]
18. In vitro toxicity evaluation of graphene oxide on A549 cells.
Chang Y; Yang ST; Liu JH; Dong E; Wang Y; Cao A; Liu Y; Wang H
Toxicol Lett; 2011 Feb; 200(3):201-10. PubMed ID: 21130147
[TBL] [Abstract][Full Text] [Related]
19. Low-Cost Synthesis of Smart Biocompatible Graphene Oxide Reduced Species by Means of GFP.
Masullo T; Armata N; Pendolino F; Colombo P; Lo Celso F; Mazzola S; Cuttitta A
Appl Biochem Biotechnol; 2016 Feb; 178(3):462-73. PubMed ID: 26490379
[TBL] [Abstract][Full Text] [Related]
20. The Structure-Properties-Cytotoxicity Interplay: A Crucial Pathway to Determining Graphene Oxide Biocompatibility.
Dziewięcka M; Pawlyta M; Majchrzycki Ł; Balin K; Barteczko S; Czerkawska M; Augustyniak M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
